The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells
Open Access
- 1 July 2000
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 83 (2), 261-266
- https://doi.org/10.1054/bjoc.2000.1237
Abstract
Bispecific antibodies (bsAb) are considered as promising tools for the elimination of disseminated tumour cells in a minimal residual disease situation. The bsAb-mediated recruitment of an immune effector cell in close vicinity of a tumour cell is thought to induce an antitumoural immune response. However, classical bispecific molecules activate only a single class of immune effector cell that may not yield optimal immune responses. We therefore constructed an intact bispecific antibody, BiUII (anti-CD3 × anti-EpCAM), that not only recognizes tumour cells and T lymphocytes with its two binding arms, but also binds and activates Fcγ-receptor positive accessory cells through its Fc-region. We have demonstrated recently that activated accessory cells contribute to the bsAb-induced antitumoural activity. We now analyse this stimulation in more detail and demonstrate here the BiUll-induced upregulation of activation markers like CD83 and CD95 on accessory cells and the induction of neopterin and biopterin synthesis. Experiments with pure cell subpopulations revealed binding of BiUll to CD64+ accessory cells and CD16+ NK cells, but not to CD32+ B lymphocytes. We provide further evidence for the importance of the Fc-region in that this bispecific molecule stimulates Fcγ-R-positive accessory cells to eliminate tumour cells in vitro by direct phagocytosis. © 2000 Cancer Research CampaignKeywords
This publication has 29 references indexed in Scilit:
- Release of Cytokines and Soluble Cell Surface Molecules by PBMC after Activation with the Bispecific Antibody CD3 × CD19Scandinavian Journal of Immunology, 1997
- CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation ModelImmunological Reviews, 1996
- Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand‐dependent pathwayEuropean Journal of Immunology, 1996
- Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion.The Journal of Experimental Medicine, 1996
- Clinical Development of 2B1, a Bispecific Murine Monoclonal Antibody Targeting c-erbB-2 and FcγRIIIJournal of Hematotherapy, 1995
- Induction of GTP-cyclohydrolase I mRNA expression by lectin activation and interferon-γ treatment in human cells associated with the immune responseJournal of Cellular Physiology, 1993
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Analysis of the tetrahydrobiopterin synthesizing system during maturation of murine reticulocytesJournal of Cellular Physiology, 1990
- Production of pteridines during hematopoiesis and T‐lymphocyte proliferation: Potential participation in the control of cytokine signal transmissionMedicinal Research Reviews, 1990
- Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.The Journal of Experimental Medicine, 1984